Market Place
Sourcing Support
All News #Library
Others
APRINOIA Therapeutics Announces Strategic Investment From The ADDF
11 Sep 2023 //
GLOBENEWSWIRE
APRINOIA Therapeutics Appoints Mark S. Shearman, Ph.D., as CEO
28 Aug 2023 //
GLOBENEWSWIRE
APRINOIA Tx Bags FDA clearance to initiate APNmAb005 Phase 1 clinical trial
11 Apr 2022 //
PRNEWSWIRE
Insilico & APRINOIA to discover next-gen compounds for neurodegenerative
31 Dec 2020 //
BIOSPECTRUMASIA
Insilico and APRINOIA to discover next-gen compounds for neurodegenerative
29 Dec 2020 //
BIOSPECTRUMASIA
APRINOIA announces NMPA approval to initiate Ph 3 clinical trial
28 Oct 2020 //
BIOSPECTRUMASIA
APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial
28 Oct 2020 //
PRNEWSWIRE
Aprinoia starts Ph 2 study of PET imaging tracer for Alzheimer`s
21 Nov 2019 //
BIOSPECTRUM ASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.